LV12125B - CYCLFILINE ROTAMASE ACTIVITIES INHIBITORS - Google Patents
CYCLFILINE ROTAMASE ACTIVITIES INHIBITORS Download PDFInfo
- Publication number
- LV12125B LV12125B LVP-98-114A LV980114A LV12125B LV 12125 B LV12125 B LV 12125B LV 980114 A LV980114 A LV 980114A LV 12125 B LV12125 B LV 12125B
- Authority
- LV
- Latvia
- Prior art keywords
- group
- neurological activity
- activity
- neurological
- fluorinated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56068595A | 1995-11-20 | 1995-11-20 | |
PCT/US1996/017677 WO1997018828A1 (fr) | 1995-11-20 | 1996-11-15 | Inhibiteurs d'activite de cyclophiline rotamase |
Publications (2)
Publication Number | Publication Date |
---|---|
LV12125A LV12125A (lv) | 1998-09-20 |
LV12125B true LV12125B (en) | 1998-12-20 |
Family
ID=24238888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-98-114A LV12125B (en) | 1995-11-20 | 1998-07-16 | CYCLFILINE ROTAMASE ACTIVITIES INHIBITORS |
Country Status (18)
Country | Link |
---|---|
US (2) | US6444643B1 (fr) |
EP (1) | EP0880358B1 (fr) |
JP (1) | JP3089350B2 (fr) |
KR (1) | KR19990071482A (fr) |
CN (1) | CN1123360C (fr) |
AT (1) | ATE246510T1 (fr) |
AU (1) | AU714482B2 (fr) |
BR (1) | BR9611624A (fr) |
CA (1) | CA2238050C (fr) |
CZ (1) | CZ154098A3 (fr) |
DE (1) | DE69629392T2 (fr) |
ES (1) | ES2206608T3 (fr) |
LV (1) | LV12125B (fr) |
MX (1) | MX9804011A (fr) |
NO (1) | NO982264L (fr) |
PL (1) | PL327994A1 (fr) |
TR (1) | TR199800890T2 (fr) |
WO (1) | WO1997018828A1 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3089350B2 (ja) * | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
AR010744A1 (es) * | 1996-12-09 | 2000-07-12 | Guildford Pharmaceuticals Inc | Inhibidores polipropilos de ciclofilina |
US6852496B1 (en) | 1997-08-12 | 2005-02-08 | Oregon Health And Science University | Methods of screening for agents that promote nerve cell growth |
WO1999010373A1 (fr) * | 1997-08-26 | 1999-03-04 | Wisconsin Alumni Research Foundation | Cyclosporines non immunosuppressives et utilisation de ces cyclosporines pour prevenir et traiter une infection par le vih |
US5968921A (en) * | 1997-10-24 | 1999-10-19 | Orgegon Health Sciences University | Compositions and methods for promoting nerve regeneration |
JP4350898B2 (ja) * | 1998-07-01 | 2009-10-21 | デビオファーム・ソシエテ・アノニム | 活性の特徴が改善された新規のシクロスポリン |
US6030825A (en) * | 1998-08-19 | 2000-02-29 | Incyte Pharmaceuticals, Inc. | Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
CA2345378A1 (fr) * | 1998-09-23 | 2000-03-30 | Marcus Keep | Neuro-immunophillines pour radioprotection neuronale selective |
US7960540B2 (en) | 1999-04-08 | 2011-06-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
EP1181304B1 (fr) | 1999-04-08 | 2007-10-10 | Antisoma Research Limited | Procede inhibant la proliferation d'oligonucleotides riches en guanosine et procede de liaison desdits oligonucleotides a la nucleoline |
US8114850B2 (en) | 1999-04-08 | 2012-02-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
US6734211B1 (en) | 1999-07-09 | 2004-05-11 | Oregon Health & Sciences University | Compositions and methods for promoting nerve regeneration |
AU7353300A (en) | 1999-09-08 | 2001-04-10 | Guilford Pharmaceuticals Inc. | Non-peptidic cyclophilin binding compounds and their use |
JP2004532187A (ja) | 2001-01-25 | 2004-10-21 | ギルフォード ファーマシュウティカルズ インコーポレイテッド | 三置換カルボサイクリックサイクロフィリン結合化合物とその用途 |
US6593362B2 (en) | 2001-05-21 | 2003-07-15 | Guilford Pharmaceuticals Inc. | Non-peptidic cyclophilin binding compounds and their use |
US20030068321A1 (en) * | 2001-09-07 | 2003-04-10 | Guilford Pharmaceuticals, Inc. | Methods of effecting neuronal activity |
US20040204340A1 (en) * | 2003-04-11 | 2004-10-14 | Guilford Pharmaceuticals, Inc. | Polyprolyl inhibitors of cyclophilin |
CN1984670A (zh) * | 2004-07-13 | 2007-06-20 | 诺瓦提斯公司 | 治疗阿尔茨海默病的环孢菌素 |
US7196161B2 (en) * | 2004-10-01 | 2007-03-27 | Scynexis Inc. | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
RU2399628C2 (ru) * | 2004-10-01 | 2010-09-20 | Скайнексис, Инк. | Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с |
JP2008545663A (ja) * | 2005-05-27 | 2008-12-18 | クイーンズ ユニバーシティ アット キングストン | タンパク質フォールディング障害の治療 |
WO2007041631A1 (fr) * | 2005-09-30 | 2007-04-12 | Scynexis, Inc. | Derives d'arylalkyle et d'heteroarylalkyle de cyclosporine a utilises pour traiter et prevenir une infection virale |
CN101511357B (zh) | 2006-05-19 | 2011-11-02 | 西尼克斯公司 | 环孢菌素类化合物及其组合物在制备治疗和预防眼部疾病的药物中的应用 |
EP2027761A1 (fr) * | 2006-06-02 | 2009-02-25 | Claude Annie Perrichon | Gestion des electrons actifs |
WO2008069917A2 (fr) * | 2006-11-20 | 2008-06-12 | Scynexis, Inc. | Nouveaux peptides cycliques |
US20080255038A1 (en) * | 2007-04-11 | 2008-10-16 | Samuel Earl Hopkins | Pharmaceutical compositions |
US8394763B2 (en) | 2007-09-26 | 2013-03-12 | Oregon Health & Science University | Cyclic undecapeptides and derivatives as multiple sclerosis therapies |
WO2010002428A2 (fr) * | 2008-06-06 | 2010-01-07 | Scynexis, Inc. | Nouveaux peptides macrocycliques |
US20130190223A1 (en) * | 2008-07-30 | 2013-07-25 | Isotechnika Pharma Inc. | Nonimmunosuppressive cyclosporine analogue molecules |
US8555875B2 (en) * | 2008-12-23 | 2013-10-15 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
CN102307892A (zh) * | 2008-12-31 | 2012-01-04 | 西尼克斯公司 | 环孢菌素a的衍生物 |
MX353720B (es) | 2010-12-15 | 2018-01-25 | Contravir Pharmaceuticals Inc | Moleculas analogas de ciclosporina modificadas en el aminoacido 1 y 3. |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0056782B1 (fr) * | 1981-01-09 | 1984-08-01 | Sandoz Ag | Cyclosporines |
EP0194972B1 (fr) * | 1985-03-11 | 1992-07-29 | Sandoz Ag | Cyclosporines |
US4764503A (en) * | 1986-11-19 | 1988-08-16 | Sandoz Ltd. | Novel cyclosporins |
US4885276A (en) * | 1987-06-03 | 1989-12-05 | Merck & Co., Inc. | Cyclosporin analogs with modified "C-9 amino acids" |
US4798823A (en) * | 1987-06-03 | 1989-01-17 | Merck & Co., Inc. | New cyclosporin analogs with modified "C-9 amino acids" |
EP0296123B1 (fr) * | 1987-06-19 | 1994-08-31 | Sandoz Ag | Peptolides cycliques |
US4914188A (en) * | 1987-11-16 | 1990-04-03 | Merck & Co., Inc. | Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin |
US5100899A (en) * | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
US5284826A (en) * | 1989-07-24 | 1994-02-08 | Sandoz Ltd. | 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins |
US5122511A (en) * | 1990-02-27 | 1992-06-16 | Merck & Co., Inc. | Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
US5385915A (en) * | 1990-05-16 | 1995-01-31 | The Rockefeller University | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
US5192773A (en) | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
EP0484281B2 (fr) * | 1990-11-02 | 2000-11-22 | Novartis AG | Cyclosporines |
US5321009A (en) | 1991-04-03 | 1994-06-14 | American Home Products Corporation | Method of treating diabetes |
US5898029A (en) | 1994-04-12 | 1999-04-27 | The John Hopkins University | Direct influences on nerve growth of agents that interact with immunophilins in combination with neurotrophic factors |
US5859031A (en) | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
US5614547A (en) * | 1995-06-07 | 1997-03-25 | Guilford Pharmaceuticals Inc. | Small molecule inhibitors of rotamase enzyme |
JP3089350B2 (ja) * | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
-
1996
- 1996-05-02 JP JP08111414A patent/JP3089350B2/ja not_active Expired - Fee Related
- 1996-11-15 WO PCT/US1996/017677 patent/WO1997018828A1/fr not_active Application Discontinuation
- 1996-11-15 KR KR1019980703753A patent/KR19990071482A/ko not_active Application Discontinuation
- 1996-11-15 ES ES96940289T patent/ES2206608T3/es not_active Expired - Lifetime
- 1996-11-15 CN CN96199455A patent/CN1123360C/zh not_active Expired - Fee Related
- 1996-11-15 CA CA2238050A patent/CA2238050C/fr not_active Expired - Fee Related
- 1996-11-15 DE DE69629392T patent/DE69629392T2/de not_active Expired - Lifetime
- 1996-11-15 TR TR1998/00890T patent/TR199800890T2/xx unknown
- 1996-11-15 CZ CZ981540A patent/CZ154098A3/cs unknown
- 1996-11-15 AT AT96940289T patent/ATE246510T1/de not_active IP Right Cessation
- 1996-11-15 AU AU77210/96A patent/AU714482B2/en not_active Ceased
- 1996-11-15 EP EP96940289A patent/EP0880358B1/fr not_active Expired - Lifetime
- 1996-11-15 BR BR9611624A patent/BR9611624A/pt not_active Application Discontinuation
- 1996-11-15 PL PL96327994A patent/PL327994A1/xx unknown
-
1998
- 1998-05-18 NO NO982264A patent/NO982264L/no not_active Application Discontinuation
- 1998-05-20 MX MX9804011A patent/MX9804011A/es unknown
- 1998-07-16 LV LVP-98-114A patent/LV12125B/en unknown
-
1999
- 1999-05-28 US US09/321,762 patent/US6444643B1/en not_active Expired - Lifetime
-
2002
- 2002-07-22 US US10/199,107 patent/US20030013645A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
LV12125A (lv) | 1998-09-20 |
EP0880358B1 (fr) | 2003-08-06 |
PL327994A1 (en) | 1999-01-04 |
ATE246510T1 (de) | 2003-08-15 |
EP0880358A1 (fr) | 1998-12-02 |
EP0880358A4 (fr) | 2001-04-18 |
US20030013645A1 (en) | 2003-01-16 |
ES2206608T3 (es) | 2004-05-16 |
KR19990071482A (ko) | 1999-09-27 |
CZ154098A3 (cs) | 1998-12-16 |
TR199800890T2 (xx) | 1998-08-21 |
JPH09143198A (ja) | 1997-06-03 |
US6444643B1 (en) | 2002-09-03 |
CN1207043A (zh) | 1999-02-03 |
MX9804011A (es) | 1998-09-30 |
AU7721096A (en) | 1997-06-11 |
AU714482B2 (en) | 2000-01-06 |
BR9611624A (pt) | 1999-06-01 |
NO982264L (no) | 1998-07-20 |
NO982264D0 (no) | 1998-05-18 |
CN1123360C (zh) | 2003-10-08 |
CA2238050A1 (fr) | 1997-05-29 |
CA2238050C (fr) | 2010-09-28 |
JP3089350B2 (ja) | 2000-09-18 |
DE69629392T2 (de) | 2004-06-24 |
DE69629392D1 (de) | 2003-09-11 |
WO1997018828A1 (fr) | 1997-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0880358B1 (fr) | Inhibiteurs d'activite de cyclophiline rotamase | |
US6245783B1 (en) | Method of using neurotrophic sulfonamide compounds | |
US5801197A (en) | Rotamase enzyme activity inhibitors | |
CN101754769B (zh) | 基于具有抗微生物活性的b型羊毛硫抗生素的用途 | |
WO2003070755A2 (fr) | Composes et compositions pour le transport de la cyclosporine a travers la barriere hemato-encephalique | |
CA2281096A1 (fr) | Methode d'utilisation de carbamates et d'urees neurotrophiques | |
US6242468B1 (en) | Carbamate and urea compositions and neurotrophic uses | |
MXPA01006449A (es) | Un agente para tratar el transtorno de la funcion de las celulas visuales. | |
JP2007532507A (ja) | 脳虚血ならびに脳および脊髄傷害の処置のためのサイクロスポリンの使用 | |
US20020013344A1 (en) | Rotamas enzyme activity inhibitors | |
DE102004011988A1 (de) | Cyclosporinderivate und diese enthaltende pharmazeutische Zusammensetzungen | |
JP4106691B2 (ja) | アナフィラトキシンC5aを不活性化するペプチド | |
AU713302C (en) | Rotamase enzyme activity inhibitors | |
US20030068321A1 (en) | Methods of effecting neuronal activity | |
MXPA98003356A (en) | Inhibitors of the activity of enzima rotam |